Publication Name	World Journal of Clinical Cases
Manuscript ID	92790
Country	Qatar

Received	2024-02-05 18:32
Peer-Review Started	2024-02-05 18:32
To Make the First Decision
Return for Revision	2024-05-18 17:10
Revised	2024-05-18 18:28
Second Decision	2024-06-14 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-14 08:37
Articles in Press	2024-06-14 08:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-06-19 21:29
Typeset the Manuscript	2024-07-31 02:48
Publish the Manuscript Online	2024-07-31 02:48

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Editorial
Article Title	Predictors of prognosis in Alzheimer’s disease: The role of cognitive dysfunction, immune abnormalities, and advanced neuroimaging
Manuscript Source	Invited Manuscript
All Author List	Hafsa Arshad Raja and Abdulqadir J Nashwan
Funding Agency and Grant Number
Corresponding Author	Abdulqadir J Nashwan, MSc, Research Scientist, Nursing Department, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa
Key Words	Amyloid beta peptide; Alzheimer's disease; Dementia; Cellular immunity; Prognosis; T lymphocytes; Magnetic resonance spectroscopy
Core Tip	Alzheimer’s disease (AD) is a serious condition leading to cognitive and social challenges. A recent study found that poor prognosis in AD patients is linked to abnormal cellular immune function, extrapyramidal symptoms, altered consciousness, abnormal electroencephalogram, increased neutrophil-lymphocyte ratio, and severe pneumonia. Impaired cellular immune function, particularly reduced T lymphocytes in the blood, is an independent predictor of poor prognosis. Early and continuous use of AD medications is associated with better outcomes.
Publish Date	2024-07-31 02:48
Citation	<p>Raja HA, Nashwan AJ. Predictors of prognosis in Alzheimer’s disease: The role of cognitive dysfunction, immune abnormalities, and advanced neuroimaging. <i>World J Clin Cases</i> 2024; 12(27): 6004-6006</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i27/6004.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i27.6004

Full Article (PDF)	WJCC-12-6004-with-cover.pdf
Manuscript File	92790_Auto_Edited_030319.docx
Answering Reviewers	92790-answering-reviewers.pdf
Audio Core Tip	92790-audio.mp3
Conflict-of-Interest Disclosure Form	92790-conflict-of-interest-statement.pdf
Copyright License Agreement	92790-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	92790-non-native-speakers.pdf
Peer-review Report	92790-peer-reviews.pdf
Scientific Misconduct Check	92790-scientific-misconduct-check.png
Scientific Editor Work List	92790-scientific-editor-work-list.pdf
CrossCheck Report	92790-crosscheck-report.pdf
CrossCheck Report	92790-crosscheck-report.png